Company / Operating Income
ResMed Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$1.7B
FY2025
5-year range
$903.7M / $1.7B
FY2021-FY2025
Trend
+27.7%
vs FY2024
Sector context
#22 of 151
Health Care
What the data says
ResMed's operating income of $1.7B is higher than 85% of companies in the Health Care sector (FY2025). Operating Income has increased for 8 consecutive years, from $426M in FY2017 to $1.7B in FY2025.
Based on SEC 10-K filings.
$1.7B in FY2025 with a 5-year CAGR of +15.8%. Top quartile in the Health Care sector.
Improved from $1.1B to $1.7B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +19.0%
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 151This company $1.7B Sector average $716.7M
▼
+135.2% above sector average
Key checks
Key Insights
- ResMed's operating income has grown for 8 consecutive years.
- 5-year CAGR of +15.8%, indicating consistent growth.
- In FY2025, operating income increased 27.7% year-over-year.
- Ranks #22 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7B | +27.7% |
| FY2024 | $1.3B | +16.6% |
| FY2023 | $1.1B | +13.2% |
| FY2022 | $1.0B | +10.7% |
| FY2021 | $903.7M | +11.6% |
| FY2020 | $809.7M | +39.8% |
| FY2019 | $579.3M | +6.9% |
| FY2018 | $541.8M | +27.3% |
| FY2017 | $425.8M | -0.7% |
| FY2016 | $429.0M | +4.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026